| abstract |
The present invention relates to new biologically active derivatives of glutarimides of the general formula (I) or their pharmaceutically acceptable salts, their use as agents for the treatment of eosinophilic diseases, mainly allergic in nature, in particular bronchial asthma, allergic rhinitis, polypous rhinusinosopathy, eosinophilic colitis, eosinophilic syndrome allergic conjunctivitis, atopic dermatitis, Cher-Strauss syndrome, anaphylactic shock, Quincke edema, eosinophilic vasculitis, eosinoph ceiling elements esophagitis, eosinophilic gastroenteritis, fibroses, pharmaceutical compositions containing glutarimide derivatives of general formula (I). |